ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer.

Adam R Wolfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.